hyperuricemia
Advertisement
A review and meta-analysis assessed the influence of SGLT2i therapy on clinically relevant hyperuricemic events.
A study examined whether urate-lowering therapy (ULT) for gout might help delay progression of chronic kidney disease (CKD).
Whether ULT should be used in CKD patients with asymptomatic hyperuricemia to prevent the progression of CKD is uncertain.
Researchers examined the roles of hyperuricemia and anemia in all-cause mortality with chronic kidney disease (CKD).
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.